Showing results (51-60 of 162) with videos related to

Sort By:
Pageof 17
Therapeutic Drug Monitoring|February 9, 2021
Can We Predict Individual Concentrations of Tacrolimus After Liver Transplantation? Application and Tweaking of a Published Population Pharmacokinetic Model in Clinical PracticeMarie-Astrid Decrocq-Rudler, Anna H-X P Chan Kwong, Lucy Meunier, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 17, 2013
A tool for selecting patients with a high probability of sustained virological response to peginterferon alfa-2a (40kD)/ribavirinPeter Ferenci, Rodrigo Aires, Ioan Ancuta, et al.
Journal of Hepatology|December 15, 2010
Treatment of chronic hepatitis C patients with the NS3/4A protease inhibitor danoprevir (ITMN-191/RG7227) leads to robust reductions in viral RNA: a phase 1b multiple ascending dose studyNicole Forestier, Dominique Larrey, Dominique Guyader, et al.
The Pharmacogenomics Journal|February 7, 2020
HLA associations with infliximab-induced liver injuryChristopher D Bruno, Brandon Fremd, Rachel J Church, et al.
Journal of Clinical Microbiology|June 22, 2007
Impact of hepatitis C virus (HCV) genotypes on quantification of HCV RNA in serum by COBAS AmpliPrep/COBAS TaqMan HCV test, Abbott HCV realtime assay [corrected] and VERSANT HCV RNA assayEdouard Tuaillon, Anne-Marie Mondain, Laure Ottomani, et al.
Transplant Immunology|February 17, 2020
Exploring predicted indirectly recognizable HLA epitopes (PIRCHE-II) in liver transplant recipients on calcineurin inhibitor-free maintenance immunosuppression. A retrospective single center studyMagdalena Meszaros, Matthias Niemann, José Ursic-Bedoya, et al.
JHEP Reports : Innovation in Hepatology|November 24, 2025
Disparities in transplant access and outcomes after first cirrhosis decompensation in alcohol-related liver diseaseJosé Ursic Bedoya, Charlotte De Choudens, Margaux Delhomme, et al.
Journal of Hepatology|April 26, 2003
Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter?Georges-Philippe Pageaux, Michael Bismuth, Pascal Perney, et al.
Transplantation|November 20, 2002
Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patientsChristophe Duvoux, Georges-Philippe Pageaux, Claire Vanlemmens, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 16, 2026
HLA-B*44 Alleles and HLA-DQA1*03:01 as Genetic Risk Factors for Drug-Induced Liver Injury due to FluoroquinolonesPaola Nicoletti, M Isabel Lucena, Raul J Andrade, et al.
Pageof 17